| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |